Evidence map›Paper›PMID 41132657›Full record

ArticleFrontiers in immunology2025

Optimizing monocyte-derived immune cell cultures: comparing xeno-free and xenogeneic conditions.

Nora Marek, Anette S B Wolff, Harsh N Dongre, Salwa Suliman

Abstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Pigs with CD163 Mutation Conferred PRRSV Resistance.Animals : an open access journal from MDPI · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nora MarekCenter for Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
Anette S B WolffEndocrine Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
Harsh N DongreCenter for Cancer Biomarkers (CCBIO) and Gade Laboratory of Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Salwa SulimanCenter for Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Culture conditions significantly affect the phenotype of immune cells. This study compared, for the first time, the impact of xeno-free human AB serum and xenogeneic fetal bovine serum (FBS) culture conditions on the surface marker expression of monocyte-derived macrophages (Mo-Mø) and dendritic cells (Mo-DC) using spectral flow cytometry. Monocytes were differentiated into macrophages or Mo-DC over 6 days. M0 macrophages were polarized toward M1-like or M2-like macrophages, and Mo-DC were activated using LPS. Differentiation was successful in both conditions. Despite cells exhibiting autofluorescence, distinct phenotypes based on selected differentiation markers were observed. CD1a expression was lacking in AB cultures, while expression of CD16, CD163 and the co-stimulatory molecules CD80 were significantly upregulated and CD86 downregulated by xenogeneic FBS conditions. These novel findings highlight the need for careful selection of serum type and phenotyping markers to minimize unexpected results and account for potential serum-induced interference with marker expressions in monocyte-derived immune cells.

Indexed as

Cell Culture TechniquesDendritic CellsMacrophagesMonocytesAnimalsAntigens, CDBiomarkersCattleCell DifferentiationCells, CulturedHumansImmunophenotypingAntigens, CDBiomarkersdendritic cellfetal bovine serumhuman AB serummacrophagespectral flow cytometry

Identifiers

PMID41132657
PMCPMC12540148

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.